Xylyx Bio Releases Advanced Disease Model System to Improve Cancer Drug Discovery

Xylyx Bio Releases Advanced Disease Model System to Improve Cancer Drug Discovery

The IN SITE™ Metastasis Kit provides key features of the cancer microenvironment to increase predictiveness and improve decision making in development of anti-cancer drugs
Interview with John O’Neil, Chief Scientific Officer of Xylyx

Interview with John O’Neil, Chief Scientific Officer of Xylyx

An inspiration and candid conversation between Dr. Mayasari Lim and upcoming 3DHEALS2020 speaker John O’Neil, Chief Scientific Officer of Xylyx, a New York-based startup focusing on creating the perfect cell environment for a variety of biotech process including biofabrication/bioprinting,...
Multiday Maintenance of Extracorporeal Lungs Using Cross-Circulation With Conscious Swine

Multiday Maintenance of Extracorporeal Lungs Using Cross-Circulation With Conscious Swine

Lung remains the least-utilized solid organ for transplantation. Efforts to recover donor lungs with reversible injuries using ex vivo perfusion systems are limited to <24 hours of support. Here, we demonstrate the feasibility of extending normothermic extracorporeal...
Evolving Tools for Accelerating 3D Cell Culture Workflows

Evolving Tools for Accelerating 3D Cell Culture Workflows

Increasingly, innovations are streamlining 3D cultures workflows.
Toxic Beauty

Toxic Beauty

A whistleblower, her lawyer, world-class scientists, cancer survivors and those who have lost their lives, strip a dominant pharmaceutical company of all credibility in this powerful documentary film while exposing the hard truths about dangerous,...
Toxic Beauty - Everything You Need to Know (with Alec Batis)

Toxic Beauty - Everything You Need to Know (with Alec Batis)

Keeping It Real: Conversations with Jillian Michaels
NBC Meet the Press

NBC Meet the Press

This year, we are premiering our first feature-length documentary.  It's called Toxic Beauty, which explores the under-regulated market for beauty and personal care products.
Xylyx Bio Announces Development of Disease-Specific Cell Culture Products to Accelerate Anti-Fibrotic Drug Discovery and Screening

Xylyx Bio Announces Development of Disease-Specific Cell Culture Products to Accelerate Anti-Fibrotic Drug Discovery and Screening

Fibrosis-specific substrates provide a disease-relevant in-vitro testing platform to inform decision-making in early-stage drug discovery
Xylyx Bio Joins Advanced Regenerative Manufacturing Institute (ARMI) Consortium

Xylyx Bio Joins Advanced Regenerative Manufacturing Institute (ARMI) Consortium

Xylyx Bio to focus on accelerating the standardization and commercialization of tissue-specific extracellular matrix biomaterials for regenerative medicine and tissue engineering